02 – Cardiovascular

Wiltshire BSW STP Antiplatelets Summary (GWH & RUH pts only)

Wiltshire INR self-testing & self-monitoring

BSW Sacubitril Valsartan for Heart Failure

Wiltshire Monoclonal antibodies for lowering cholesterol – Prescribing advice

Wiltshire Omega-3 - advisory summary

Wiltshire How should conversion between doxazosin formulations be carried out in patients with hypertension

Wiltshire Diltiazem Dosing Regimes

Wiltshire Compression and Lymphoedema Garments

NICE Hypertension Guidance

NICE Hypertension Guidance – Patient Decision Aid

Direct Oral Anticoagulants (DOACs – formerly NOACs)

BSW Guidance on converting between anticoagulants

BSW PrescQIPP Atrial fibrillation: Patient information and decision aid

BSW PrescQIPP Prescriber decision support - Warfarin

BSW PrescQIPP Patient information - Non-vitamin K antagonist oral anticoagulants (NOACs)

BSW PrescQIPP Comparison of novel oral anticoagulants (NOACs)

BSW PrescQIPP Drug interactions with NOACs

BSW PrescQIPP Considerations for anticoagulationin Venous Thrombo-embolism (VTE)

BSW Direct Oral Anticoagulants (DOACs) for DVT and PE in adults: Local pathways

BSW PrescQIPP Anticoagulation Bulletin

BSW PrescQIPP Anticoagulation Briefing


Wiltshire Management of Lipids in Primary Care